M Ventures led a series A round for UNC's RNA therapy spinout, while Amgen, Illumina, AbbVie and Mitsubishi Tanabe Pharma also took part.

Vrije Universiteit Brussel’s Camel-IDS collected funding from investors including Novo for a radiation-based oncology platform that will initially target Her2-positive brain metastatic breast cancer.

University of Louisville Foundation alleges its spinout pharmacogenetics spinout PGxL was unable to repay a loan it had guaranteed after the business fell into bankruptcy.

OSI is among the investors in drone developer Animal Dynamics’ latest round, which will help it develop products based on aerodynamics from the animal kingdom.

Tokyo telemedicine spinout Miup has been backed by Beyond Next Ventures in its bid to build an AI-powered healthcare ecosystem in Bangladesh.

Online higher education platform Unicaf has raised series B funding from a consortium also including Goldman Sachs, EdX and CDC Group as it gears up to target more students.

The cybersecurity commercialisation firm hopes to raise $2.9m through an Aim placement and will use the funding for product development, working capital, sales and marketing.

The funding from crowdfunding platform SyndicateRoom is part of a wider series B round for Manchester gel therapy developer Gelmetix and adds to approximately $1.3m raised in 2014 and 2015.

Kebotix has emerged from Harvard University with backing from investors including Baidu to commercialise an automated approach to discovering new materials and molecules.

Boehringer Ingelheim and Helsinn helped University of Geneva vaccine spinout Amal reach the second close of a series B round that now totals $32.7m.